Modest Protective Effects Of Isoflavones From A Red Clover-derived Dietary Supplement On Cardiovascular Disease Risk Factors In Perimenopausal Women, And Evidence Of An Interaction With ApoE Genotype In 49-65 Year-old Women
|Trial Design||Double blind|
|Trial Length||6+ Months|
|Number of Subjects||177|
43.5mg of red clover isoflavones daily for one year has failed to significantly improve cardiovascular risk factors, and when controlling for the ApoE genotype there was a stronger trend for inprovement that still failed to reach statistical significance.